JW Therapeutics: Funding, Investors & Team (Oct 2026)
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.The company focuses on development, transformation and promotion of cell-based immunotherapies that uses chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to regulate the body's immune system, enabling doctors to save the lives of cancer patients and improve the quality of life.
JW Therapeutics has raised $100M across 1 funding round on record, the most recent an undisclosed round of $100M announced in Jun 2020.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
JW Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2020.
JW Therapeutics Funding Rounds
JW Therapeutics Founders and Leadership Team
Contact details for the JW Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →JW Therapeutics Funding Compared to Other Biotechnology Startups
JW Therapeutics' latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like JW Therapeutics in Biotechnology and Shanghai
Companies Similar to JW Therapeutics
Protoga is a biotech firm that focused on the development of innovative microalgae biosynthesis technology.
Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET…
NewLine researches phage feed additives to prevent livestock infections.
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic…
Salus BioMed is an innovative biomedical company that specializes in developing genetic sequencing technology…
Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the…
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of…
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The…
BioLinker is a creation of manufactured science, protein blend packs, and protein.
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
JW Therapeutics Funding FAQs
What does JW Therapeutics do?
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.The company focuses on development, transformation and promotion of cell-based immunotherapies that uses chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to regulate the body's immune system, enabling doctors to save the lives of cancer patients and improve the quality of life.
How much funding has JW Therapeutics raised?
JW Therapeutics has raised $100M across 1 round on record. The most recent is an undisclosed round of $100M announced in Jun 2020.
When did JW Therapeutics last raise funding?
JW Therapeutics' most recent funding round on record is an undisclosed round of $100M, announced in Jun 2020.
Who is the CEO of JW Therapeutics?
James Li is listed as CEO at JW Therapeutics.
Where is JW Therapeutics headquartered?
JW Therapeutics is based in Shanghai, China.
How many employees does JW Therapeutics have?
JW Therapeutics is in the 51-100 employee band.
How does JW Therapeutics' funding compare to other Biotechnology startups?
JW Therapeutics' latest round of $100M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's JW Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for JW Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.